AYA

ARTRYA FPO [AYA]
Artrya Limited, a medical technology company, engages in the development and commercialization of artificial intelligence platform that detects, diagnoses, and address coronary artery disease in Australia. It offers Salix, a suite of cloud-based software that uses artificial intelligence to automate the detection of coronary artery disease from coronary computed tomography angiography scans to identify and manage patients at risk of a heart attack. The company was incorporated in 2018 and is based in West Perth, Australia.
Healthcare · ASX Small Cap
$4.0200 +2.8%

Updated 9 Sep 2026 · Signals refresh every scan

Appeared in 2 consecutive scansFirst seen: 2026-03-19
Get alerts when AYA triggers a new signal
Free watchlist with daily scans for 2,200+ ASX stocks
Track AYA — Free

Active Signals

Bullish Signals

  • RSI drifting toward oversold territory — worth watching
  • Stochastic is deep in oversold territory — bounce conditions forming
  • Above-average volume (1.6x) on a green day — buyers stepping up
  • Drifting lower — down 3.8% over the last 5 days
  • Lagging the Small Ords index — relative strength of 0.88, underperforming its peers
  • Strong cash runway (16 quarters)
  • Very high P/S ratio (23453.9x)
  • EPS estimates revised upward (+10pts)
  • Capital raise activity (2 events)
  • Dilution velocity warning (2 raises recently)
  • CANSLIM I: Institutional ownership (37%)
  • Sentiment is mixed — no strong consensus either way
  • Positive long-term momentum — up 25% over the past year
  • Elevated dilution risk (2 recent capital raises)
  • RBA hiking (-3pts)
  • Calendar: Clinical Trial in 14d (+5pts)

Risk Signals

  • Trading below both moving averages — the trend is working against this one
  • Below the 200-day average — the long-term trend is still working against it
  • Revenue declining (-7%)
  • Piotroski F-Score weak (3/9, low-confidence approx)
  • Not enough chatter to gauge sentiment — defaulting to neutral
  • The bigger volume days are the down days — volume-weighted momentum is negative (-0.88%/day)

Expected next for AYA

23 Sep 2026Clinical Trial UpdateEstimated from past filings
Window: 12 Sep to 4 Oct
The last 3 moved AYA +12.9% on the day, on average — an observation, not a guide to what happens next.
5 Nov 2026Quarterly Cash Flow Report (4C)Estimated from past filings
Window: 29 Oct to 12 Nov
The last 3 moved AYA -6.5% on the day, on average — an observation, not a guide to what happens next.
Each date is labelled with how it is known. A date estimated from past filings is inferred from this company's own filing rhythm — it is not a confirmed date and not a statement about what the company intends to do. See the whole ASX calendar →

Recent Catalysts

NONE Application for quotation of securities - AYA
NONE Issue of Shares on Exercise of Securities & Cleansing Notice
NONE S&P DJI Announces September 2026 Quarterly Rebalance
Announcement tone +3pts

Recent ASX Announcements

2026-09-08 Application for quotation of securities - AYA
2026-09-08 Issue of Shares on Exercise of Securities & Cleansing Notice
2026-09-04 S&P DJI Announces September 2026 Quarterly Rebalance PRICE SENSITIVE
2026-09-01 Application for quotation of securities - AYA
2026-09-01 Issue of Shares on Exercise of Securities & Cleansing Notice

Key Metrics

$656.7M
Market Cap
810K
Avg Volume
1.6x
Vol Ratio
$2.09 — $6.49
52-Week Range
2.3%
Short Interest
N/A
Cash Runway
-50.6%
ROE
N/A
Profit Margin

CANSLIM Analysis

FactorRatingDetail
CCurrent EPSfailEPS Growth: 0%
AAnnual EarningsfailCAGR: 0%
NNew Highs / Catalystsneutral
SSupply & DemandneutralFloat: 71%
LLeader vs LaggardlaggardRS: -8
IInstitutional SponsorshippassInst: 37%
MMarket DirectionneutralNeutral

Sector: Healthcare

110 tickers in this sector

View all Healthcare signals →Browse all ASX tickers A–Z →
Related Tickers
NUZ +37.1%IPD +20.0%HIQ +16.7%AVE +15.0%CVB +11.1%
Compare:AYA vs NUZAYA vs IPDAYA vs HIQ
Share this analysis

Track AYA and 2,200+ ASX stocks

Get free access to Scout's AI-powered dashboard with daily scans, watchlist alerts, and exit management for every ASX small cap.

Open Dashboard — Free Free Screener
No credit card required